Skip to main content

Deep Vein Thrombosis (DVT) and Total Knee Arthroplasty

  • Chapter
Surgical Techniques in Total Knee Arthroplasty

Conclusion

As orthopedic surgeons, we are all biased by our personal opinions and experiences. This is very evident when looking at the DVT prophylaxis patterns used by individual surgeons. Although comparing 30 years of DVT data is similar to comparing apples to oranges (or perhaps the entire fruit basket!), some trends have become evident. Recent well-designed studies discussed above cast doubt on the previous confidence in ASA and warfarin. Although no prophylaxis method is ideal, mechanical compression devices and low molecular weight heparin appear promising. Further studies are needed to evaluate this true DVT rate when these modalities are both utilized. Together, as is done at many institutions, the length of therapy required must also be better defined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Le Clerc JR, Geerts WH, Des Jardins L, La Flamme GH, L’Esperance BL, Demers C, Kassis J, Cruickshank M, Whitmore L, Delorme F. Prevention of venous thromboembolism after knee arthroplasty a randomized double blind trial comparing Enoxaparin with warfarin. ANN Intern Med. 1996; 124:619–626.

    Google Scholar 

  2. Pidala MJ, Donovan DL, Kepley RF. A prospective study on intermittent pneumatic compression in the prevention of deep vein thrombosis in patients undergoing total hip or total knee replacement. Surg-General-Obstet. 1992; 175: 47–51.

    CAS  Google Scholar 

  3. Anders MJ, Lifeso RM, Landis M, Mikulsky J, Meinking C, McCracken KS. Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee. J Bone Joint Surg. 1996; 78-A:574–580.

    Google Scholar 

  4. Sharrock NE, Sculco TP, Ranawat CS, Maynard MJ, Harpel PC. Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet. J Arthroplasty. 1995; 10:523–526.

    Article  CAS  PubMed  Google Scholar 

  5. Stulberg BN, Francis CW, Pellegrini VD, Miller ML, Shull S, DeSwart R, Easley K, Totterman S, Marden VJ. Antithrombin III/low dose heparin in the prevention of deep vein thrombosis after total knee arthroplasty. Clin Orthop. 1989; 248:152–157.

    PubMed  Google Scholar 

  6. Sharrock NE, Hargett MJ, Urquhart B, Peterson MGE, Ranawat C, Insall J, Windsor R. Factors affecting deep vein thrombosis rate following total knee arthroplasty under epidural anesthesia. J Arthroplasty. 1993; 8:133–139.

    CAS  PubMed  Google Scholar 

  7. Kim YH. The incidence of deep vein thrombosis after cementless and cemented knee replacement. J Bone Joint Surg. 1990; 72:779–783.

    CAS  Google Scholar 

  8. Liu GC, Ferris EJ, Reifsteck JR, et al. Effect of anatomical variations on deep vein thrombosis of the lower extremity. Am J Roentgenol. 1986; 146:845–848.

    CAS  Google Scholar 

  9. Virchow R. Neuer Fall von Todticher, Embolie der Lungenarterien 1856. Arch Pathol Anat. 10:225–228.

    Google Scholar 

  10. Ginsberg JS, Brill-Edwards P, Panju A, Patel A, McGinnis J, Smith F, Dale I, Johnston M, Ofosu F. Preoperative plasma levels of thrombin-antithrombin II complex correlate with the development of venous thrombosis after major hip or knee surgery. Thrombosis and Haemostasis. 1995; 74:602–605.

    CAS  PubMed  Google Scholar 

  11. Stulberg BW, Lucas FV, Belhobek GU. Anti-thrombin III as a marker of venous thromboembolism: a preliminary report. Trans Orthop Res Soc. 1984; 9:100.

    Google Scholar 

  12. Morrey BF. Joint Replacement Arthroplasty. New York: Churchill Livingston; 1991:67–82.

    Google Scholar 

  13. Lambie JM, et al. Diagnostic accuracy in venous thrombosis. Br Med J. 1970; 2:142–143.

    CAS  PubMed  Google Scholar 

  14. Canale ST. Campbell’s Operative Orthopaedics. St. Louis: Mosby; 1998:270–285.

    Google Scholar 

  15. Albrechtsson U, Olsson CG. Thrombotic side effects of lower limb venography. Lancet. 1976; 1:723–724.

    CAS  PubMed  Google Scholar 

  16. Thomas ML, MacDonald LM. Complications of ascending phlebography of the leg. Br Med J. 1978; 2:317–318.

    CAS  PubMed  Google Scholar 

  17. Borris LC, Christiansen HM, Lassen MR, et al. Comparison of real time B-mode ultrasonography and bilateral ascending phlebography for detection of postoperative deep vein thrombosis following elective hip surgery. Thromb Haemost. 1989; 61:363–365.

    CAS  PubMed  Google Scholar 

  18. Sadler DA. Diagnosis of deep-vein thrombosis comparison of clinical evaluation, ultrasound, plethysmography and venoscan with x-ray venogram. Lancet. 1984;716–719.

    Google Scholar 

  19. Harris WH, Athanasoulis C, Waltman AC, Salzman EW. Cuff-impedance phlebography and 125I fibrinogen scanning versus roentenographic phlebography for diagnosis of thrombophlebitis following hip surgery. J Bone Joint Surg. Am. 1976; 58(7):938–944.

    Google Scholar 

  20. Mullick SC, Wheeler HB, Songser GF. Diagnosis of deep venous thrombosis by measurement of electrical impedance. Am J of Surg. 1970; 119:417–423.

    CAS  Google Scholar 

  21. Lotke PQ, Palevsky H, Keenan AM, Meranze S, Steingerg ME, Ecker ML, Kelly MA. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop. 1996; 324:251–258.

    PubMed  Google Scholar 

  22. Haas SB, Tribos CB, Insall JN, Becker MW, Windsor RE. The significance of calf thrombi after total knee arthroplasty. J Bone Joint Surg Br. 1992; 74(B)-6:799–802.

    CAS  PubMed  Google Scholar 

  23. Philbrick T, Becker DM. Calf deep venous thrombosis-a wolf in sheep’s clothing? Arch Intern Med. 1988; 148:2131–2138.

    Article  CAS  PubMed  Google Scholar 

  24. Mudge M, Hughes LE. The long-term sequelae of deep vein thrombosis. Br J Surg. 1978; 65:692–694.

    CAS  PubMed  Google Scholar 

  25. Warwick D, Perez J, Vicker C, Bannister G. Does total hip arthroplasty predispose to chronic venous insufficiency. J Arthrop. 1996; II(5):529–533.

    Google Scholar 

  26. Hedner T, Everts B. The early clinical history of salicylates in rheumatology and pain. Clin Rheumatol. 1998; 17(1): 17–25.

    Article  CAS  PubMed  Google Scholar 

  27. Mann CC, Plummer ML. The Aspirin Wars: Money, Medicine and 100 Years of Ramant Competition. New York: Knopf; 1991.

    Google Scholar 

  28. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. NEJM. 1991; 324(I): 27–35.

    CAS  PubMed  Google Scholar 

  29. Craven LL. Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Mississippi Valley Med J. 1953; 75:38–42.

    CAS  Google Scholar 

  30. Weiss HJ, Aledort LM, Kockwa S. The effect of salcylates on the hemostatic properties of platelets in man. J Clin Invest. 1986; 47:2169–2180.

    Google Scholar 

  31. Mustard JF, Packham MA. Factors influencing platelet function: adhesion, release and aggregation. Pharmacol Rev. 1970; 22:97–187.

    CAS  PubMed  Google Scholar 

  32. DeLee JC, Rockwood CA. The use of aspirin in thromboemboli disease. J Bone Joint Surg 1980; 62(A):149–152.

    Google Scholar 

  33. Salzman EW, Harris WH, DeSanctis RW. Reduction in venous thromboembolism by agents affecting platelet function. NEJM. 1971; 284:1287–1292.

    CAS  PubMed  Google Scholar 

  34. Patrono C. Aspirin as an antiplatelet drug. NEJM. 1994; 330(18):1287–1294.

    Article  CAS  PubMed  Google Scholar 

  35. Roth GJ, Calverley DC. Aspirin, platelets and thrombosis: theory and practice. Blood. 1994; 83(4):885–989.

    CAS  PubMed  Google Scholar 

  36. Campbell WB. Lipid-derived autocoids: eicosanoids and platelet activation factor. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990.

    Google Scholar 

  37. McKenna R, Bachmann F, Kaushal SP, Galante JO. Thromboembolic disease in patients undergoing total knee replacement. J Bone Joint Surg. 1976; 58-A:928–932.

    Google Scholar 

  38. McKenna R, Galante J, Bachmann F, et al. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med Journal. 1980; 280:514–517.

    CAS  Google Scholar 

  39. Haas SB, Insall JB, Scuderi GR, Windsor RE, Ghelman B. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg. 1990; 72-A:27–31.

    Google Scholar 

  40. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. J Bone Joint Surg. 78A (6):826–834.

    Google Scholar 

  41. Hirsh J, Dalen JE, Deykin E, et al. Oral anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Chest. 1992; 102(supp 4):312S–326S.

    CAS  PubMed  Google Scholar 

  42. O’Reilly RA. Lack of effect of fortified wine injested during fasting and anticoagulant therapy. Arch Intern Med. 1981; 141:458–459.

    CAS  PubMed  Google Scholar 

  43. O’Reilly, Aggeler PM, Hoag MS, et al. Hereditary transmission of exceptional resistance to coumadin anticoagulant drugs. NEJM. 1983; 308:1229–1230.

    Google Scholar 

  44. Lieberman JR, Gererts WH. Prevention of venous thromboembolism in orthopaedic patients. J Bone Joint Surg. 1976; 58(A)(7):903–913.

    Google Scholar 

  45. Sutherland CJ, Schurman JR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop. 1987; 219:158–162.

    PubMed  Google Scholar 

  46. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Current use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Inter Med. 1993; 153:165–170.

    Article  Google Scholar 

  47. Laflamme GH, Laflamme GE, Paiment, Beaumont P. Efficacy and safety of low dose warfarin prophylaxis in cemented total knee prosthesis. Ann Chir. 1994; 48(8):717–722.

    CAS  PubMed  Google Scholar 

  48. Lotke PQ, Palevsky H, Keenan MA, Meranze S, Steingerg ME, Ecker ML, Kelly MA. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop. 1996; 324:251–258.

    PubMed  Google Scholar 

  49. Hodge WA. Prevention of deep vein thrombosis after total knee arthroplasty. Clin Orthop. 1991; 271:101–105.

    PubMed  Google Scholar 

  50. Clasett TP, Anderson FA Jr, Heit J, et al. Prevention of venous thromboembolism. Chest. 1995; 108(suppl):3125–3345.

    Google Scholar 

  51. Salzman EW, Harris WH. Prevention of venous thromboembolism in orthopaedic patients. J Bone Joint Surg. 1976; 58A(7):903–913.

    Google Scholar 

  52. Allenby F, Boardman L, Pflug J, Calnan J. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet. 1973; 2:1412–1414.

    CAS  PubMed  Google Scholar 

  53. Weitz J, Michelsen J, Gold K, Owen J, Carpenter D. Effects of intermittent pneumatic calf compression on postoperative thrombin and plasmin activity. Thromb and Haemost. 1986; 56:198–201.

    CAS  Google Scholar 

  54. Gardner AM, Fox RH. The venous pump of the human foot: preliminary report. Bristol Med Chir J. 1983; 98:109–114.

    CAS  PubMed  Google Scholar 

  55. Wilson NV, Das SK, Maurice H, et al. Thrombosis prophylaxis in total knee replacement. Br J Surg. 1992; 74(1): 50–52.

    CAS  Google Scholar 

  56. Wilson NV, Das SK, Smibert MG, Thomas EM, Kakkar VV. Thrombosis prophylaxis in total knee replacement: does a simple mechanical method help? Br J Surg. 1992; 77(12):1417.

    Google Scholar 

  57. Zimlich RH, Fulbright M, Friedman RJ. Current status on anticoagulation therapy after total hip and total knee arthroplasty. JAAOS. 1996; 4(1):54–62.

    Google Scholar 

  58. RD Heparin Arthroplasty Group. RD heparin compared with warfarin for the prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am. 1994; 76:1174–1185.

    Google Scholar 

  59. Heit J, Berkowitz S, Bona R, Comp P, Corson J, Cushner F, Ellio G, Garino J, Lyons R, Ohar J, Holloway S, Zacquis L. Efficacy and safety of Normiflo (A LMWH) compared to warfarin for prevention of venous thromboembolism following total knee replacement: a doubleblind dose-ranging study. Thromb Haemost. 1997; 77(1): 32–38.

    CAS  PubMed  Google Scholar 

  60. Hull R, Raskob G, Brant R. A comparison of subcutaneous low-molecular weight heparin with warfarin for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med. 1993; 329(19):1370–1376.

    Article  CAS  PubMed  Google Scholar 

  61. Levine MN, Gent M, Hirsh J, Wertz J, et al. Ardeparin (low molecular weight heparin) vs. graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. Arch Intern Med. 1996; 156:851–856.

    Article  CAS  PubMed  Google Scholar 

  62. Leclerc JR, Geerts WH, DesJardins L, et al. Prevention of deep vein thrombosis after major knee surgery: a randomized double blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost. 1992; 67:417–423.

    CAS  PubMed  Google Scholar 

  63. Leclerc JR, Geerts WN, DesJardins L, I’Esporance B, Cruikshank M, et al. Prevention of venous thromboembolism (WTE) after knee arthroplasty-a randomized double-blind trial comparing a low molecular-weight heparin fragment (enoxaparin) to warfarin. Ann Int Med. 1996; 124(7): 619–626.

    CAS  PubMed  Google Scholar 

  64. Spiro TE, Fitzgerald RH, Trowbridge AA, et al. Enoxaparin a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery. Blood. 1993; 82:410A (abstract).

    Google Scholar 

  65. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep vein thrombosis following total knee replacement. J Bone Joint Surg. 1984; 66A(2):194–201.

    Google Scholar 

  66. Sutherland CJ, Schurman JR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop. 1987; 219:158–162.

    PubMed  Google Scholar 

  67. Ansari S, Warwick D, Ackroyd CE, Newman MA. Incidence of fatal pulmonary embolism after 1390 knee arthroplasties without routine prophylactic anticoagulation except in high risk cases. J Arthrop. 1997; 12(C):599–602.

    CAS  Google Scholar 

  68. Uresilovic EJ, Hozack WJ, Booth RE, Rothman RN. Incidence of pulmonary embolism after total knee arthroplasty with low dose coumadin prophylaxis. Clin Orthop. 1993; (286):27–31.

    Google Scholar 

  69. Petersdorf RG. Harrison’s Principles of Internal Medicine. Aukland: McGraw-Hill; 1983:1565.

    Google Scholar 

  70. Sabiston DC. Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 15th ed. W.B. Saunders Co.; 1997: 1602–1606.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Cushner, G.B., Cushner, F.D., Cushner, M.A. (2002). Deep Vein Thrombosis (DVT) and Total Knee Arthroplasty. In: Scuderi, G.R., Tria, A.J. (eds) Surgical Techniques in Total Knee Arthroplasty. Springer, New York, NY. https://doi.org/10.1007/0-387-21714-2_92

Download citation

  • DOI: https://doi.org/10.1007/0-387-21714-2_92

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-98389-9

  • Online ISBN: 978-0-387-21714-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics